创新药概念
创新药板块以新分子实体与差异化机制药物研发为核心，覆盖靶向与免疫治疗、ADC、基因与细胞疗法，以及药物发现、临床开发到商业化全链条。板块总市值达 1806.51 billion HKD，24h 涨跌幅 -0.33%，40 个标的中上涨 17 个（占比 42.50%），下跌 21 个（占比 52.50%）。领涨个股为 四环医药 (00460)，24h 涨幅 +6.81%。该板块在涨跌参差的走势中回落，尽管龙头股表现更好。保持精选：围绕临床或政策催化事件进行交易；偏好现金充足、处于后期临床阶段的管线，并在走弱时逢低加仓，因为利率和报销信号正在影响估值。
名称 | 最新价 | 涨跌幅 | 最新价 / 涨跌幅 | 走势图 | 价格区间 | 操作 |
|---|---|---|---|---|---|---|
 石药集团01093 | HK$8.30¥7.17 | -2.92%-¥0.21 | HK$8.30 -2.92% | ¥7.16¥7.38 | ||
 药明生物02269 | HK$38.66¥33.41 | -1.12%-¥0.38 | HK$38.66 -1.12% | ¥33.25¥34.27 | ||
 信达生物－B01801 | HK$89.35¥77.21 | -0.66%-¥0.51 | HK$89.35 -0.66% | ¥76.61¥77.95 | ||
 药明康德02359 | HK$157.0¥135.6 | -0.25%-¥0.3 | HK$157.0 -0.25% | ¥135.1¥138.1 | ||
 百济神州06160 | HK$199.7¥172.5 | +0.25%+¥0.4 | HK$199.7 +0.25% | ¥170.9¥173.1 | ||
 金斯瑞生物科技01548 | HK$16.82¥14.53 | +4.47%+¥0.62 | HK$16.82 +4.47% | ¥13.88¥14.53 | ||
 康方生物09926 | HK$98.60¥85.21 | -0.90%-¥0.77 | HK$98.60 -0.90% | ¥84.13¥86.16 | ||
 晶泰控股02228 | HK$7.17¥6.19 | -0.41%-¥0.02 | HK$7.17 -0.41% | ¥5.99¥6.28 | ||
 科伦博泰生物－B06990 | HK$513.5¥443.7 | -0.09%-¥0.4 | HK$513.5 -0.09% | ¥438.1¥449.4 | ||
 三生制药01530 | HK$17.13¥14.80 | -0.86%-¥0.12 | HK$17.13 -0.86% | ¥14.64¥14.93 | ||
 荣昌生物09995 | HK$85.65¥74.02 | +2.94%+¥2.11 | HK$85.65 +2.94% | ¥71.90¥74.54 | ||
 康诺亚－B02162 | HK$82.30¥71.12 | -0.60%-¥0.43 | HK$82.30 -0.60% | ¥70.30¥71.99 | ||
 中国生物制药01177 | HK$5.09¥4.39 | -1.16%-¥0.05 | HK$5.09 -1.16% | ¥4.38¥4.45 | ||
 四环医药00460 | HK$0.94¥0.81 | +6.81%+¥0.05 | HK$0.94 +6.81% | ¥0.75¥0.82 | ||
 药明合联02268 | HK$54.35¥46.97 | -2.16%-¥1.03 | HK$54.35 -2.16% | ¥46.58¥48.65 | ||
 翰森制药03692 | HK$32.30¥27.91 | +0.18%+¥0.05 | HK$32.30 +0.18% | ¥27.70¥28.10 | ||
 恒瑞医药01276 | HK$57.05¥49.30 | +0.70%+¥0.34 | HK$57.05 +0.70% | ¥48.95¥49.78 | ||
 先声药业02096 | HK$12.62¥10.90 | -0.86%-¥0.09 | HK$12.62 -0.86% | ¥10.80¥11.06 | ||
 再鼎医药09688 | HK$14.87¥12.85 | -3.31%-¥0.44 | HK$14.87 -3.31% | ¥12.71¥13.33 | ||
 巨子生物02367 | HK$29.04¥25.09 | +0.48%+¥0.12 | HK$29.04 +0.48% | ¥24.97¥25.51 |